Concepedia

Publication | Open Access

Treating Metastatic Solid Tumors With Bortezomib and a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Agonist Antibody

DOIFull Paper Access

83

Citations

47

References

2008

Year

Anil Shanker, Ari D. Brooks, Carlos A Tristan, John W. Wine, Peter J. Elliott, Hideo Yagita∥, Kazuyoshi Takeda, Mark J. Smyth, William J. Murphy, T. J. Sayers
JNCI Journal of the National Cancer Institute

Abstract

Bortezomib combined with DR5 agonist monoclonal antibody may be a useful treatment for metastatic solid tumors.

References

YearCitations

Page 1